| |||
| Combination of | |||
|---|---|---|---|
| Clofexamide | Antidepressant | ||
| Phenylbutazone | Nonsteroidal anti-inflammatory drug | ||
| Clinical data | |||
| Trade names | Perclusone | ||
| Routes of administration | Oral, rectal, topical | ||
| ATC code | |||
| Legal status | |||
| Legal status |
| ||
| Identifiers | |||
| CAS Number | |||
| PubChem CID | |||
| ChemSpider | |||
| UNII | |||
| CompTox Dashboard (EPA) | |||
| ECHA InfoCard | 100.037.681  | ||
| (what is this?) (verify) | |||
Clofezone (trade name Perclusone) is a drug that was used to treat joint and muscular pain, but is not marketed any more. It is a combination of clofexamide, an antidepressant, and phenylbutazone, a nonsteroidal anti-inflammatory drug (NSAID).
References
- Berger A, Wachter H, eds. (1998). Hunnius Pharmazeutisches Wörterbuch (in German) (8 ed.). Walter de Gruyter Verlag. p. 343. ISBN 3-11-015793-4.
- Reinicke C, Helbing M, Klingenfeld U, Lasaroff I, Wessel G (December 1984). "". Die Pharmazie. 39 (12): 824–7. PMID 6241720.
| Non-steroidal anti-inflammatory drugs (NSAIDs) (primarily M01A and M02A, also N02BA) | |
|---|---|
| pyrazolones / pyrazolidines | |
| salicylates | |
| acetic acid derivatives and related substances | |
| oxicams | |
| propionic acid derivatives (profens) |
|
| n-arylanthranilic acids (fenamates) | |
| COX-2 inhibitors (coxibs) | |
| other | |
| NSAID combinations | |
| Key: underline indicates initially developed first-in-class compound of specific group; WHO-Essential Medicines; withdrawn drugs; veterinary use. | |
| Topical products for joint and muscular pain (M02) | |||||||
|---|---|---|---|---|---|---|---|
| Anti-inflammatory preparations, non-steroids |
| ||||||
| Capsaicin derivatives | |||||||
| Other | |||||||
 | This drug article relating to the musculoskeletal system is a stub. You can help Misplaced Pages by expanding it. |